Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for ...

CMS finalized a rule that fundamentally changes Medicare payment methodology for a broad range of skin substitute products used for wound care. Beginning in January 2026, most skin substitute products ...

UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure ...

Mesoblast shares are up 59.59% over the year, recovering from a 45% crash earlier this year due to tariff impacts, with shares currently trading at $2.32.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced ...

Q3 2025 Earnings Call Transcript November 6, 2025 Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $0 ...

VentureMed Group, Inc., a leading medical device company specializing in vessel preparation and access management ...

PRINCETON, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, toda ...

Mesoblast Limited (NASDAQ:MESO) is one of the best hot stocks to invest in. On October 3, Mesoblast Limited announced that its product Ryoncil (remestemcel-L-rknd) was assigned a specific Healthcare ...

Oklahoma residents will see 280 new laws take effect on Nov. 1, impacting everything from driving and alcohol-related ...